{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs2012, Part I

Activity Steps

1 Activity
2 Take Test 3Certificate

Purpose of Activity

To provide nurses with information on a selection of recently approved drugs.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Discuss indications for these new drugs.
  2. Identify common adverse reactions associated with these new drugs.
  3. Explain nursing considerations for administration of these new drugs.

Disclosures

The author and planners have disclosed that they have no financial relationships related to this article.

Price: $29.95

Credits:

  • ANCC 3.5 CH / 3.5 APH
  • DC - BON 3.5 CH
  • DC - BON 3.5 CH
  • KY-BON 3.5 CH
  • KY-BON 3.5 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
--------------------------------------------------
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
--------------------------------------------------
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.

Awarded Advanced Pharmacology Hours.









Planner
Test Code: N0312A
Published: March 2012
Expires: 12/31/2026
Sources: Nursing2020
Required Passing Score: 27/36 (75%)
Authors: Daniel A. Hussar PhD
Categories: Drug Therapy , Management , Oncology , Pediatrics
Specialties: Home Health, Hospice and Palliative Care, Infection Control, Management, Maternal-Child, Medical-Surgical, Oncology, Pediatric, Surgery, Urology
Topics: Dialysis